The Cloudbased Drug Discovery Platform Market To Traverse The Exponential Growth Trajectory Between 2025

PersistenceMarketResearch, in its report entitled “The Cloudbased Drug Discovery Platform Market”, paves the way for every technological advancement through which the healthcare industry is evolving. While preparing the report, every parameter has been considered – right from the inception of that particular thing in healthcare industry to the end-results and the role modern-day research and technology play therein. 

A new report by Persistence Market Research presents interesting facets of the global cloud-based drug discovery platform market and provides value forecasts for an eight year period from 2017 to 2025. The report titled ‘Cloud-based Drug Discovery Platform Market: Global Industry Analysis (2012 – 2016) and Forecast (2017–2025)’ is a comprehensive take on the global cloud-based drug discovery platform market and highlights the different factors anticipated to impact market revenue growth during the said period.

According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/11020

Company Profiles

• IBM Corporation
• Accenture PLC
• Tata Consultancy Services Limited
• SAS Institute Inc.
• BioXcel Corporation
• Cloud Pharmaceuticals Inc.
• WuXi AppTec (Sanghai) Co. Ltd.
• Dassault System
• Acelot, Inc.
• Others.

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

• Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency
• Traction in the adoption of machine learning and artificial intelligence for drug discovery
• Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/11020

Growth challenges

• Concerns regarding infrastructure compatibility issues
• Issues pertaining to interoperability of applications with devices

Market trends

• Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North America region
• Rising adoption of cloud-based mobile applications for collaborative drug discovery

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%.

Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period.

The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period.

In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

Top Reports of Persistence Market Research :-

Active Pharmaceutical Ingredient Market – Persistence Market Research predicts that the global active pharmaceutical ingredients market to exhibit a CAGR above 4% over the forecast period (2021-2031).

Opioids Market – According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).

Autogenous Vaccines Market – According to a revised report published by Persistence Market Research, the autogenous vaccines market was valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR of 5.5% over the forecast period (2021-2031).

About us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com